Cardiometabolic Complications in People with HIV
A Special Issue of Viruses (ISSN 1999-4915) belonging to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: 30 April 2027 | Viewed by 121
Editor
2. Office of the President, South Africa Medical Research Council, Cape Town, South Africa
Interests: HIV; cardiovascular disease; cardiometabolic disease; antiretroviral therapy
Special Issue Information
Dear Colleagues,
People living with HIV have a twofold risk of developing cardiovascular disease, including myocardial infarction, heart failure, and stroke. Women living with HIV have even higher risk of cardiovascular complications compared to males. This increased cardiovascular risk in HIV is driven by chronic, low-grade systematic inflammation, the virus itself, opportunistic infections, comorbid traditional risk factors, and metabolic effects of certain antiretroviral therapies. This Special Issue will welcome manuscripts on the epidemiology, natural history, pathophysiological mechanisms, clinical burden, and outcome of cardiometabolic complications and multimorbidity (e.g., cardiovascular disease, stroke, dyslipidemia, and insulin resistance) in people living with HIV. In addition, articles focusing on integrative analyses of chronic inflammation, immune activation, and antiretroviral therapy-related metabolic disturbances to identify biomarkers and therapeutic interventions will form part of the scope of this Special Issue.
Dr. Ntobeko Ntusi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV
- cardiovascular disease
- cardiometabolic disease
- HIV-associated cardiometabolic disease
- antiretroviral therapy
- inflammation
- immune activation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
